Beyond laser microdissection technology: follow the yellow brick road for cancer research

Legres, Luc G.; Janin, Anne; Masselon, Christophe; Bertheau, Philippe
January 2014
American Journal of Cancer Research;2014, Vol. 4 Issue 1, p1
Academic Journal
Normal biological tissues harbour different populations of cells with intricate spacial distribution patterns resulting in heterogeneity of their overall cellular composition. Laser microdissection involving direct viewing and expertise by a pathologist, enables access to defined cell populations or specific region on any type of tissue sample, thus selecting near-pure populations of targeted cells. It opens the way for molecular methods directed towards well-defined populations, and provides also a powerful tool in studies focused on a limited number of cells. Laser microdissection has wide applications in oncology (diagnosis and research), cellular and molecular bio- logy, biochemistry and forensics for tissue selection, but other areas have been gradually opened up to these new methodological approaches, such as cell cultures and cytogenetics. In clinical oncology trials, molecular profiling of microdissected samples can yield global "omics" information which, together, with the morphological analysis of cells, can provide the basis for diagnosis, prognosis and patient-tailored treatments. This remarkable technology has brought new insights in the understanding of DNA, RNA, and the biological functions and regulation of proteins to identify molecular disease signatures. We review herein the different applications of laser microdissection in a variety of fields, and we particularly focus attention on the pre-analytical steps that are crucial to successfully perform molecular-level investigations.


Related Articles

  • Imaging: Glowing success. Novak, Kristine // Nature Reviews Cancer;Jun2004, Vol. 4 Issue 6, p418 

    Reports that although many targeted anticancer drugs prove effective when tested in biochemical assays in 2004, it is another matter to determine how they affect molecular targets in vivo. Key issues of interest; Analysis of pertinent topics and relevant issues; Implications on cancer research.

  • Novel Cell and Tissue Acquisition System (CTAS): Microdissection of Live and Frozen Brain Tissues. Kudo, Lili C.; Vi, Nancy; Ma, Zhongcai; Fields, Tony; Avliyakulov, Nuraly K.; Haykinson, Michael J.; Bragin, Anatol; Karsten, Stanislav L. // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    We developed a novel, highly accurate, capillary based vacuum-assisted microdissection device CTAS - Cell and Tissue Acquisition System, for efficient isolation of enriched cell populations from live and freshly frozen tissues, which can be successfully used in a variety of molecular studies,...

  • Availability and quality of paraffin blocks identified in pathology archives: A multi-institutional study by the Shared Pathology Informatics Network (SPIN). Patel, Ashokkumar A.; Gupta, Dilipkumar; Seligson, David; Hattab, Eyas M.; Balis, Ulysses J.; Ulbright, Thomas M.; Kohane, Isaac S.; Berman, Jules J.; Gilbertson, John R.; Dry, Sarah; Schirripa, Osvaldo; Hong Yu; Becich, Michael J.; Parwani, Anil V. // BMC Cancer;2007, Vol. 7, p37 

    Background: Shared Pathology Informatics Network (SPIN) is a tissue resource initiative that utilizes clinical reports of the vast amount of paraffin-embedded tissues routinely stored by medical centers. SPIN has an informatics component (sending tissue-related queries to multiple institutions...

  • Scaffolding protein GOPC regulates tight junction structure. Lu, Ruifeng; Stewart, Lorraine; Wilson, Jean // Cell & Tissue Research;May2015, Vol. 360 Issue 2, p321 

    GOPC (FIG/PIST/CAL) is a PDZ-domain scaffolding protein that regulates the trafficking of a wide array of proteins, including small GTPases, receptors and cell surface molecules such as cadherin 23 and cystic fibrosis transmembrane regulator. In Madin-Darby canine kidney (MDCK) cells, we find...

  • Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. Pantaleo, Maria Abbondanza; Nicoletti, Giordano; Nanni, Cristina; Gnocchi, Chiara; Landuzzi, Lorena; Quarta, Carmelo; Boschi, Stefano; Nannini, Margherita; Di Battista, Monica; Castellucci, Paolo; Fanti, Stefano; Lollini, Pier Luigi; Bellan, Elena; Castelli, Mauro; Rubello, Domenico; Biasco, Guido // Journal of Experimental & Clinical Cancer Research (17569966);2010, Vol. 29, p173 

    Background: Primary and secondary drug resistance to imatinib and sunitinib in patients with gastrointestinal stromal tumors (GISTs) has led to a pressing need for new therapeutic strategies such as drug combinations. Most GISTs are caused by mutations in the KIT receptor, leading to upregulated...

  • Rapid discrimination of malignant lesions from normal gastric tissues utilizing Raman spectroscopy system: a meta-analysis. Ouyang, Huan; Xu, Jiahui; Zhu, Zhengjie; Long, Tengyun; Yu, Changjun // Journal of Cancer Research & Clinical Oncology;Oct2015, Vol. 141 Issue 10, p1835 

    Objectives: To systematically analyze the diagnostic accuracy of Raman spectroscopy system (RAS) in the rapid diagnosis of gastric cancer with histopathology as the reference standard. Methods: We searched a wide range of electronic databases for all published researches that assessed the...

  • Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma. Stoker, Sharon; Novalić, Zlata; Wildeman, Maarten; Huitema, Alwin; Verkuijlen, Sandra; Juwana, Hedy; Greijer, Astrid; Tan, I.; Middeldorp, Jaap; Boer, Jan // Journal of Cancer Research & Clinical Oncology;Oct2015, Vol. 141 Issue 10, p1845 

    Purpose: Despite successful primary treatment of nasopharyngeal carcinoma (NPC), the incidence of distant metastasis remains 25-34 %. Treatment options are limited, and survival is poor. Intratumoural Epstein-Barr virus (EBV) was used as treatment target. In NPC, EBV is present in a latent...

  • The need for integrative computational oncology: an illustrated example through MMP-mediated tissue degradation. Mumenthaler, Shannon M.; D'Antonio, Gianluca; Preziosi, Luigi; Macklin, Paul // Frontiers in Oncology;Jul2013, Vol. 3, p1 

    Physical oncology is a growing force in cancer research, and it is enhanced by integrative computational oncology: the fusion of novel experiments with mathematical and computational modeling. Computational models must be assessed with accurate numerical methods on correctly scaled tissues to...

  • Breast cancer: Establishing normality. Flintoft, Louisa // Nature Reviews Cancer;Jun2004, Vol. 4 Issue 6, p418 

    Cites key findings findings from a research in 2004 that used tissue left over from breast-reduction surgery to isolate the two main cell types that give rise to breast carcinomas. Luminal cells of the ductal-lobular system; Myoepithelial cells of the ductal-lobular system; Implications on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics